Innovative mRNA vaccine against NSCLC
Designing a platform of targeted polymeric nanoparticles
for efficient personalized therapy.
Innovative mRNA vaccine against NSCLC
Designing a platform of targeted polymeric nanoparticles
for efficient personalized therapy.
About the project
We aim to design a personalized enhanced and combined nano-immunotherapeutic approach to treat lung cancer patients, based on the use of proprietary polymeric nanoparticles encapsulating nucleic acids as active principles.
These nucleic acids will:
a) act as antigens to immunize patients against tumor antigens and achieve the self-killing of tumor cells (mRNA cancer vaccination); and
b) immunomodulate the TME by silencing key immunosuppressor genes (targeted therapy).
countries
research institutes
involved
balance
News
The last partner is the group of Dr. Niehaus and Dr. Bednarz, from @CeBiTec @unibielefeld . They are experts on advanced imaging techniques, so they will characterize the nanoparticles biodistribution in vivo.
2
#DonesRecerca
馃煟La Dra. @CFornagueraP, professora d鈥橧QS, coordina el projecte europeu @TumorOut, que t茅 com a objectiu dissenyar una vacuna terap猫utica pel c脿ncer de pulm贸 basada en la revolucion脿ria tecnologia de vacunes de mRNA amb nanopart铆cules.
https://bit.ly/3kYdhNh
馃摚 L'Associaci贸 @ContraCancerBCN ha concedit finan莽ament al projecte @TumorOut, liderat per la professora i investigadora d'IQS @CFornagueraP.
L'objectiu del projecte 茅s trobar una vacuna terap猫utica contra el c脿ncer de pulm贸 basada en nanomedicina.
Moltes gr脿cies! 馃憦馃徏 https://twitter.com/ContraCancerBCN/status/1635608291530231809
Ahir es va dur a terme l鈥檃cte amb els investigadors i investigadores que lideren els projectes guanyadors de les beques de l鈥橝sociacio a la seu de Barcelona. Seguim sumant per aconseguir el 70% de superviv猫ncia en c脿ncer pel 2030 馃挌 馃敩 #investigandoenc谩ncer